vs 125I-Sauvagine (RG) | vs 125I-Sauvagine + GTPγS (RO) | vs [3H]NBI 35965 + GTPγS (R) | vs 125I-Astressin + GTPγS (R) | ||||||
---|---|---|---|---|---|---|---|---|---|
Antagonist Ligand | pKi | % Maximal Displacement | pKi | % Maximal Displacement | pKi | % Maximal Displacement | pKi | % Maximal Displacement | α |
nM | nM | nM | nM | ||||||
Antalarmin | 9.42 ± 0.03 | 101 ± 1 | 8.71 ± 0.08 | 92 ± 3 | 9.22 ± 0.26 | 101 ± 2 | 8.07 ± 0.15a | 20 ± 1 | 0.63 ± 0.03a |
(0.38) | (2.0) | (0.61) | (8.6) | ||||||
NBI 27914 | 9.02 ± 0.06 | 100 ± 1 | 8.70 ± 0.18 | 113 ± 13 | 8.68 ± 0.06 | 99 ± 2 | 8.95 ± 0.06a | 28 ± 1 | 0.59 ± 0.01a |
(0.97) | (2.0) | (2.1) | (1.1) | ||||||
NBI 35965 | 8.84 ± 0.10 | 99 ± 1 | 8.33 ± 0.10 | 94 ± 6 | 8.74 ± 0.06 | 100 | 8.87 ± 0.33a | 22 ± 1 | 0.65 ± 0.03a |
(1.4) | (4.6) | (1.8) | (1.4) | ||||||
DMP-696 | 8.63 ± 0.11 | 101 ± 1 | 8.38 ± 0.08 | 110 ± 3 | 8.71 ± 0.07 | 98 ± 2 | 8.89 ± 0.22a | 32 ± 2 | 0.54 ± 0.02a |
(2.3) | (4.1) | (2.0) | (1.3) |
Displacement of radioligand binding to L-CRF1 cell membranes was measured as described under Materials and Methods. Inhibition of 125I-sauvagine binding provides a measure of ligand affinity for the RG state of the CRF1receptor. Ligand affinity for the R state was measured by displacement of 125I-astressin or [3H]NBI 35965 binding in the presence of 30 μM GTPγS. A third state of the receptor was identified in L-CRF1 cell membranes, which bound agonists with high affinity in a GTPγS-insensitive manner (RO). Ligand affinity for RO was measured by displacement of125I-sauvagine binding with 30 μM GTPγS present. pK i values were obtained by fitting the displacement data to a single affinity-state competition model, followed by conversion of IC50 to K i(Cheng and Prusoff, 1973). [In all cases, a two affinity-state model did not significantly improve the goodness of fit (p > 0.05)]. The K d value used in theK i calculation was 43 pM and 1.4 nM for125I-sauvagine at RG and RO, respectively, 0.56 nM for [3H]NBI 35965, and 70 pM for125I-astressin.
a The affinity of nonpeptide antagonists was determined using a model which assumes allosteric inhibition of125I-astressin binding (the allosteric ternary model, eq.1; see , pK i is equivalent to pK N in eq. 1). This analysis estimates nonpeptide affinity, and the cooperativity between nonpeptide and125I-astressin binding (α). Data are the mean ± S.E.M. (n = 3–4).